Rituximab is a safe and effective long-term treatment for children with steroid and calcineurin inhibitor-dependent idiopathic nephrotic syndrome

Pietro Ravani, Alessandro Ponticelli, Chiara Siciliano, Alessia Fornoni, Alberto Magnasco, Felice Sica, Monica Bodria, Gianluca Caridi, Changli Wei, Mirco Belingheri, Luciana Ghio, Sandra Merscher-Gomez, Alberto Edefonti, Andrea Pasini, Giovanni Montini, Corrado Murtas, Xiangyu Wang, Daniel Muruve, Augusto Vaglio, Davide MartoranaAntonello Pani, Francesco Scolari, Jochen Reiser, Gian M. Ghiggeri

Research output: Contribution to journalArticlepeer-review

83 Scopus citations

Fingerprint

Dive into the research topics of 'Rituximab is a safe and effective long-term treatment for children with steroid and calcineurin inhibitor-dependent idiopathic nephrotic syndrome'. Together they form a unique fingerprint.

Medicine & Life Sciences